MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...
Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined ...
Advances strategic shift toward a disciplined research model prioritizing external innovation to accelerate rare disease pipeline growth- ...
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...
Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...
The ambitious overhaul places uncrewed platforms at the center of future UK forces operations on land, at sea, and in the air ...
Claude Science, Anthropic’s new AI research workbench, launched in beta July 1 for all paid subscribers — no enterprise vetting required. The platform uses multi-agent orchestration across 60-plus ...
Diranersen presentation will feature Phase 2 CELIA data in early Alzheimer's disease, including clinical, biomarker and safety results for Biogen's investigational tau-targeting ASO, following topline ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing ...
OpenAI hardware team gains Paul Meade, Apple’s VP who spent seven years building the Vision Pro and was leading its smart ...
Cisco will cut 471 California jobs despite record Q3 FY2026 revenue of $15.8 billion, as the company restructures to invest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results